The University of Jena, officially the Friedrich Schiller University Jena, is a public research university located in Jena, Thuringia, Germany. The university was established in 1558 and is counted among the ten oldest universities in Germany.

During the past decade, Friedrich-Schiller University conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Friedrich-Schiller University" #1 sponsor was "University of Jena" with 12 trials, followed by "Bayer" with 6 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Friedrich-Schiller University" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator and "Dr. Gerlind Schneider" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Friedrich-Schiller University" are "Acute Myeloid Leukemia" (2 trials), "Cystic Fibrosis" (2 trials), "Heart Failure" (2 trials), "Hypercholesterolemia" (2 trials) and "Malignant Melanoma" (2 trials). Many other conditions were trialed in "Friedrich-Schiller University" in a lesser frequency.

Most popular intervention types in "Friedrich-Schiller University" are "Drug" (21 trials), "Dietary Supplement" (9 trials), "Device" (8 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CancerVax vaccine (CANVAXIN)" (2 trials), "linseed oil" (2 trials), "3 months of dual antiplatelet therapy (DAPT)" (1 trials) and "APBSCT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Friedrich-Schiller University" are 42 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Friedrich-Schiller University". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Friedrich-Schiller University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Friedrich-Schiller University, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".

Friedrich-Schiller University has several departments that took part in Clinical trials: "Friedrich Schiller University Jena, Department of Nutritional Physiology" - 7 trials